Richard G. Ghalie
2021
In 2021, Richard G. Ghalie earned a total compensation of $1.1M as Chief Medical Officer at MEI Pharma.
Compensation breakdown
| Non-Equity Incentive Plan | $118,065 |
|---|---|
| Option Awards | $522,750 |
| Salary | $432,481 |
| Stock Awards | $69,800 |
| Total | $1,143,096 |
Ghalie received $522.8K in option awards, accounting for 46% of the total pay in 2021.
Ghalie also received $118.1K in non-equity incentive plan, $432.5K in salary and $69.8K in stock awards.
Rankings
In 2021, Richard G. Ghalie's compensation ranked 8,318th out of 12,405 executives tracked by ExecPay. In other words, Ghalie earned more than 32.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,318 out of 12,405 | 33rd |
Division Manufacturing | 3,678 out of 5,494 | 33rd |
Major group Chemicals And Allied Products | 1,634 out of 2,369 | 31st |
Industry group Drugs | 1,453 out of 2,090 | 31st |
Industry Pharmaceutical Preparations | 1,080 out of 1,537 | 30th |
Source: SEC filing on October 28, 2021.
Ghalie's colleagues
We found four more compensation records of executives who worked with Richard G. Ghalie at MEI Pharma in 2021.